US Patent 7432364 Human TIMP-1 antibodies
Patent 7432364 was granted and assigned to Bayer Healthcare on October, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andreas M. Knorr0
Barbara Krebs0
Clark Pan0
Claudia Hirth-Dietrich0
Michael Schauer0
Sabine Kraft0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+370 characters)
Article
Patent abstract
Human antibodies that bind to TIMP-1 can be used as reagents to diagnose and treat disorders in which TIMP-1 is elevated, such as liver fibrosis, alcoholic liver disease, cardiac fibrosis, acute coronary syndrome, lupus nephritis, glomerulosclerotic renal disease, benign prostate hypertrophy, colon cancer, lung cancer, and idiopathic pulmonary fibrosis.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07432364 Human TIMP-1 antibodies US Patent 7432364 Human TIMP-1 antibodies
Infobox
Patent Number
074323640
Patent Number
74323640
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
074323640
Date of Patent
October 7, 2008
0Patent Application Number
115045270
Date Filed
August 14, 2006
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07432364 Human TIMP-1 antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07432364
Date of patent
October 7, 2008
Patent application number
11504527
Date Filed
August 14, 2006
Patent primary examiner
Find more entities like US Patent 7432364 Human TIMP-1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
